An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196

NCT01485952 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

55

Enrollment

INDUSTRY

Sponsor class

Conditions

Huntington Disease

Interventions

DRUG: SEN0014196 (Low Dose)
DRUG: SEN0014196 (High Dose)
DRUG: Placebo

Sponsor

Siena Biotech S.p.A.

Collaborators

[object Object]
[object Object]